Analysts think DARE stock price could increase by 1340%
Aug 01, 2024, 6:27 AM
4.71%
What does DARE do
Daré Bioscience, Inc., a healthcare company based in San Diego, specializes in developing and commercializing pharmaceuticals for women's reproductive health, including products like XACIATO for bacterial vaginosis. The company, which launched its IPO in 2014, has a range of products in development, such as Ovaprene, a hormone-free contraceptive, and Sildenafil Cream for female sexual arousal disorder.
6 analysts think DARE stock price will increase by 1340.00%. The current median analyst target is $48.96 compared to a current stock price of $3.40. The lowest analysts target is $24.24 and the highest analyst target is $75.60.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
